SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-21-014009
Filing Date
2021-03-18
Accepted
2021-03-18 07:30:11
Documents
14
Period of Report
2021-05-03

Document Format Files

Seq Description Document Type Size
1 DEF 14A vtvt-def14a_20210503.htm DEF 14A 833058
2 GRAPHIC giqbdy40bfyy000002.jpg GRAPHIC 8234
3 GRAPHIC giqbdy40bfyy000001.jpg GRAPHIC 21916
4 GRAPHIC giqbdy40bfyy000009.jpg GRAPHIC 839
5 GRAPHIC giqbdy40bfyy000011.jpg GRAPHIC 839
6 GRAPHIC giqbdy40bfyy000007.jpg GRAPHIC 900
7 GRAPHIC giqbdy40bfyy000010.jpg GRAPHIC 900
8 GRAPHIC giqbdy40bfyy000005.jpg GRAPHIC 900
9 GRAPHIC giqbdy40bfyy000006.jpg GRAPHIC 839
10 GRAPHIC giqbdy40bfyy000004.jpg GRAPHIC 839
11 GRAPHIC giqbdy40bfyy000008.jpg GRAPHIC 839
12 GRAPHIC giqbdy40bfyy000012.jpg GRAPHIC 281865
13 GRAPHIC giqbdy40bfyy000003.jpg GRAPHIC 900
14 GRAPHIC giqbdy40bfyy000013.jpg GRAPHIC 200743
  Complete submission text file 0001564590-21-014009.txt   1552794
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37524 | Film No.: 21753099
SIC: 2834 Pharmaceutical Preparations